363 related articles for article (PubMed ID: 28046096)
1. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
Oliveira MF; Chaillon A; Nakazawa M; Vargas M; Letendre SL; Strain MC; Ellis RJ; Morris S; Little SJ; Smith DM; Gianella S
PLoS Pathog; 2017 Jan; 13(1):e1006112. PubMed ID: 28046096
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR.
de Oliveira MF; Gianella S; Letendre S; Scheffler K; Kosakovsky Pond SL; Smith DM; Strain M; Ellis RJ
PLoS One; 2015; 10(10):e0139510. PubMed ID: 26431315
[TBL] [Abstract][Full Text] [Related]
3. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
Pérez-Santiago J; De Oliveira MF; Var SR; Day TRC; Woods SP; Gianella S; Mehta SR
J Neurovirol; 2017 Apr; 23(2):283-289. PubMed ID: 27921220
[TBL] [Abstract][Full Text] [Related]
4. Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.
Spudich S; Robertson KR; Bosch RJ; Gandhi RT; Cyktor JC; Mar H; Macatangay BJ; Lalama CM; Rinaldo C; Collier AC; Godfrey C; Eron JJ; McMahon D; Jacobs JL; Koontz D; Hogg E; Vecchio A; Mellors JW
J Clin Invest; 2019 Jul; 129(8):3339-3346. PubMed ID: 31305262
[TBL] [Abstract][Full Text] [Related]
5. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
de Almeida SM; Rotta I; Ribeiro CE; Oliveira MF; Chaillon A; de Pereira AP; Cunha AP; Zonta M; Bents JF; Raboni SM; Smith D; Letendre S; Ellis RJ
J Neurovirol; 2017 Jun; 23(3):460-473. PubMed ID: 28247269
[TBL] [Abstract][Full Text] [Related]
6. Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
Chaillon A; Gianella S; Lada SM; Perez-Santiago J; Jordan P; Ignacio C; Karris M; Richman DD; Mehta SR; Little SJ; Wertheim JO; Smith DM
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142136
[TBL] [Abstract][Full Text] [Related]
7. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
[TBL] [Abstract][Full Text] [Related]
8. Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.
Katusiime MG; Halvas EK; Wright I; Joseph K; Bale MJ; Kirby-McCullough B; Engelbrecht S; Shao W; Hu WS; Cotton MF; Mellors JW; Kearney MF; van Zyl GU
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776265
[TBL] [Abstract][Full Text] [Related]
9. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.
Sturdevant CB; Joseph SB; Schnell G; Price RW; Swanstrom R; Spudich S
PLoS Pathog; 2015 Mar; 11(3):e1004720. PubMed ID: 25811757
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.
Sharma V; Creegan M; Tokarev A; Hsu D; Slike BM; Sacdalan C; Chan P; Spudich S; Ananworanich J; Eller MA; Krebs SJ; Vasan S; Bolton DL;
PLoS Pathog; 2021 Dec; 17(12):e1010105. PubMed ID: 34874976
[TBL] [Abstract][Full Text] [Related]
13. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
[TBL] [Abstract][Full Text] [Related]
15. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.
Pérez-Santiago J; Schrier RD; de Oliveira MF; Gianella S; Var SR; Day TR; Ramirez-Gaona M; Suben JD; Murrell B; Massanella M; Cherner M; Smith DM; Ellis RJ; Letendre SL; Mehta SR
J Neurovirol; 2016 Apr; 22(2):191-200. PubMed ID: 26428514
[TBL] [Abstract][Full Text] [Related]
16. Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence.
Spudich S; Peterson J; Fuchs D; Price RW; Gisslen M
AIDS; 2019 Dec; 33 Suppl 2():S135-S144. PubMed ID: 31789814
[TBL] [Abstract][Full Text] [Related]
17. CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy.
Guha D; Misra V; Yin J; Gabuzda D
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766236
[TBL] [Abstract][Full Text] [Related]
18. Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
Ulfhammer G; Edén A; Mellgren Å; Fuchs D; Zetterberg H; Hagberg L; Nilsson S; Yilmaz A; Gisslén M
AIDS; 2018 Sep; 32(15):2171-2178. PubMed ID: 30005007
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.
Jumare J; Sunshine S; Ahmed H; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Umlauf A; Cherner M; Abimiku A; Charurat M; Li JZ; Blattner WA; Royal W
J Neurovirol; 2017 Jun; 23(3):474-482. PubMed ID: 28243867
[TBL] [Abstract][Full Text] [Related]
20. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
Premeaux TA; D'Antoni ML; Abdel-Mohsen M; Pillai SK; Kallianpur KJ; Nakamoto BK; Agsalda-Garcia M; Shiramizu B; Shikuma CM; Gisslén M; Price RW; Valcour V; Ndhlovu LC
J Neurovirol; 2019 Apr; 25(2):150-161. PubMed ID: 30478799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
